Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared on LinkedIn:
”Latest publication from the Sydney Centres for Thrombosis and Haemostasis.
This one ably led by one of my Charles Sturt University (CSU) PhD students, Mohammad Altememi, based at Liverpool Hospital, NSW Health Pathology, and his primary supervisor Prof. Abishek B. Santhakumar, with additional co-supervision from another of my CSU colleagues, Md Zahid Islam.
Free to download from that great Q1 journal Clinical Chemistry and Laboratory Medicine.”
Read the full article here.
Article: Artificial intelligence and machine learning in thrombosis and hemostasis: a scoping review of clinical and laboratory applications, challenges, and future directions
Authors: Mohammad A. Altememi, Emmanuel J Favaloro, Zahid Islam, Abishek. B. Santhakumar
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 21, 2026, 18:08Roberta Gualtierotti: Point-of-Care SPR Device for Rapid Detection of Anti-PEG Antibodies
-
Jun 21, 2026, 17:59Fakhrul Abedin Jon: Exploring Types of Brain Bleeding
-
Jun 21, 2026, 17:00Jeffrey Schnur: Advanced Treatment Strategies for Deep Vein Thrombosis and Pulmonary Embolism
-
Jun 21, 2026, 16:53Matteo Foschi: When Should We Restart Anticoagulation After a Breakthrough Ischemic Stroke?
-
Jun 21, 2026, 16:33Dua Asim: Efficacy and Safety of Rivaroxaban Plus Aspirin in PAD Patients
-
Jun 21, 2026, 16:21Early Gains in Stroke Knowledge With Stroke Riskometer – International Journal of Stroke
-
Jun 21, 2026, 16:12Cost Savings and Reduced Factor Consumption With Efanesoctocog Alfa – Blood Journals Portfolio
-
Jun 21, 2026, 15:59John Jaksich: Heparin and Anticoagulants – Chemistry, Biotechnology, and Manufacturing
-
Jun 21, 2026, 15:11Mishal Khan: Long-Term Mortality Trends and Demographic Disparities in Patients With PE and AF